Fosaprepitant 150 mg/5mL

Fosaprepitant 150 mg/5mL is a lyophilized powder for solution, used for managing chemotherapy-induced nausea and vomiting. This intravenous injection is designed for single-dose administration.

Fosaprepitant is primarily used to prevent nausea and vomiting caused by chemotherapy. It belongs to a class of medications known as substance P/neurokinin 1 (NK1) receptor antagonists. This medication is often administered before chemotherapy to help manage these side effects. Fosaprepitant works by blocking neurotransmitters in the brain that trigger nausea and vomiting.

Common effects of Fosaprepitant may include fatigue, headache, and diarrhea. Some individuals might experience infusion-related reactions such as flushing or rash. These effects are generally mild and temporary. Always consult a healthcare provider for personalized advice.

Fosaprepitant should be used with caution in patients with a history of severe allergic reactions to similar medications. It is important to inform your healthcare provider about any other medications you are taking to avoid potential interactions. Follow the prescribed dosage and administration instructions carefully.

Fosaprepitant may interact with other medications, including those metabolized by the liver's cytochrome P450 system. It is important to discuss all current medications with your healthcare provider to avoid potential interactions. Avoid consuming alcohol while using Fosaprepitant, as it may increase the risk of side effects.